FARABURSEN SODIUM
UNII AW823VA36X

Substance Identification & Data

This profile provides standardized clinical and technical data for Farabursen Sodium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) AW823VA36X.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2921918-19-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

AW823VA36X

CAS Registry Number

2921918-19-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

FARABURSEN SODIUM

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C215736

National Cancer Institute reference terminology for clinical and research data.

USAN ID

MN-146

Identifier assigned by the United States Adopted Names Council.

Substance Type

nucleicAcid

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Farabursen Sodium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

FARABURSEN SODIUM

Common Names & Synonyms

FARABURSEN SODIUM [USAN]

RNA, (P-THIO)((2',5'-ANHYDRO-6'-DEOXY-4'-C-(HYDROXYMETHYL)-.ALPHA.-L-MANNOFURANO)A-(3'->4')-(2',5'-ANHYDRO-6'-DEOXY-4'-C-(HYDROXYMETHYL)-.ALPHA.-L-MANNOFURANO)G-CM-(2'-DEOXY-2'-FLUORO)A-(2'-DEOXY-2'-FLUORO)C-(2'-DEOXY-2'-FLUORO)U-UM-(3'->4')-(2',5'-ANHYDRO-6'-DEOXY-4'-C-(HYDROXYMETHYL)-.ALPHA.-L-MANNOFURANO)U-(3'->4')-(2',5'-ANHYDRO-6'-DEOXY-4'-C-(HYDROXYMETHYL)-.ALPHA.-L-MANNOFURANO)A), SODIUM SALT (1:8)